The Patient Protection and Affordable Care Act made a significant investment in comparative effectiveness research (CER), a promising tool for determining the most effective strategies for treating different patients. Yet certain populations – including racial and ethnic minorities, the elderly, children, people with disabilities and those with multiple chronic conditions – are often underrepresented in health care research and therefore may not realize the same benefit from CER as the general population. To effectively reduce health care disparities and improve the quality and value of care for all patients, CER must address the needs of these priority populations.
NOTE: The audio for the keynote address is truncated at the very beginning, due to technical difficulties.
On June 3, the Engelberg Center for Health Care Reform at Brookings hosted a forum to identify challenges and opportunities for using CER to improve the health of priority populations. Experts and key stakeholders discussed methods for setting research priorities that can improve care, examined infrastructure needs for conducting research and addressed specific barriers to getting from better evidence to better care – all with specific focus on these priority groups.
After each panel, participants took audience questions.
Agenda
-
June 3
-
Welcome and Introductory Remarks
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke University -
Keynote Address
-
Panel 1: Setting Research Priorities that Improve Care for Vulnerable Populations
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke UniversityModerator: Garth Graham Office of Minority Health, U.S. Department of Health and Human ServicesRichard Hodes Director, National Institute on AgingLisa Iezzoni Professor of Medicine, Harvard Medical School and Mongan Institute for Health PolicyNancy Roizen Professor of Pediatrics and Chief, Developmental-Behavioral Pediatrics and Psychology -
Panel 2: Expanding Infrastructure and Capacity for Conducting CER in Priority Populations
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke UniversityRuth Brannon Director, Division of Research Sciences, National Institute on Disability and Rehabilitation ResearchNewell McElwee Executive Director, U.S. Outcomes Research GroupRuth Shaber Medical DirectorPhilip Wang Deputy Director -
Panel 3: Using Evidence to Improve Care for Priority Populations
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke UniversityMichael Cropp President and Chief Executive OfficerJean D. Moody-Williams Group Director, Quality Improvement GroupMargaret K. O’Bryon President and Chief Executive OfficerGretchen Clark Wartman Vice President, Policy and ProgramElena Rios President and Chief Executive Officer -
Closing Remarks
Mark B. McClellan Former Brookings Expert, Director, Margolis Center for Health Policy - Duke University
-